Why the study?
Does chronic oral amiodarone therapy increase defibrillation energy requirements in patients with implantable defibrillators?
Does chronic oral amiodarone therapy increase defibrillation energy requirements in patients with implantable defibrillators?
Chronic oral amiodarone therapy significantly increases defibrillation energy requirements in patients with implantable defibrillators, which correlates with serum drug concentrations.
Answers are grounded in this paper and cite their sources.
Amiodarone was associated with higher defibrillation thresholds; leaves open whether routine threshold testing or device reprogramming is warranted in ICD patients.
INTRODUCTION: The effect of oral amiodarone therapy on defibrillation energy requirements in patients with an implantable defibrillator has not been established. METHODS AND RESULTS: Twenty-one consecutive patients with implantable biphasic waveform defibrillators underwent a step-down determination of the defibrillation energy requirement 211 +/- 12 days before and 73 +/- 22 days after initiation of amiodarone therapy (mean total dose 26.7 +/- 11.1 g). Serum amiodarone and desethylamiodarone concentrations were measured at the time of defibrillation energy requirement determination. The mean defibrillation energy requirement before amiodarone therapy was 9.9 +/- 4.6 J. After initiation of amiodarone therapy, the mean defibrillation energy requirement increased to 13.7 +/- 5.6 J (P = 0.004). A linear relationship between the amiodarone (P = 0.02, r = 0.6), desethylamiodarone (P = 0.02, r = 0.6), and combined amiodarone-desethylamiodarone concentrations (P = 0.01, r = 0.6) and the defibrillation energy requirement was noted. Stepwise regression analysis demonstrated that the combined amiodarone-desethylamiodarone concentration was the only independent predictor of increase in the defibrillation energy requirement. CONCLUSION: Chronic oral amiodarone therapy increases the defibrillation energy requirement by approximately 62% in patients with an implantable defibrillator. The combined amiodarone-desethylamiodarone concentration is directly related to the increase in the defibrillation energy requirement.
No takes yet. Share an insight, caveat, or question.
Pelosi et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: